Atossa Therapeutics, Inc. (ATOS): Total Assets
$47.61M
As of 2025-12-31
$32.28M
As of 2026-06-30
-27.2%
3-year compound annual growth
+2.1%
5-year compound annual growth
+22.5%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $47.61M | -37.7% | 2026-03-25, Balance as of period end |
| 2024-12-31 | $76.44M | -20.6% | 2026-03-25, Balance as of period end |
| 2023-12-31 | $96.25M | -22.1% | 2025-03-25, Balance as of period end |
| 2022-12-31 | $123.53M | -12.6% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $141.26M | +229.8% | 2023-03-22, Balance as of period end |
| 2020-12-31 | $42.84M | +195.6% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $14.49M | +23.6% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $11.72M | +43.6% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $8.16M | +97.0% | 2019-03-28, Balance as of period end |
| 2016-12-31 | $4.14M | -33.6% | 2018-03-08, Balance as of period end |
| 2015-12-31 | $6.24M | -46.9% | 2017-03-21, Balance as of period end |
| 2014-12-31 | $11.76M | -2.0% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $12.01M | +75.9% | 2015-03-30, Balance as of period end |
| 2012-12-31 | $6.83M | +122.2% | 2014-03-27, Balance as of period end |
| 2011-12-31 | $3.07M | n/a | 2013-03-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Atossa Therapeutics, Inc. (ATOS) | 2025-12-31 | $47.61M | -37.7% |
| Akari Therapeutics Plc (AKTX) | 2025-12-31 | $47.89M | -5.3% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $47.13M | -12.9% |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $48.56M | -42.4% |
| Unicycive Therapeutics, Inc. (UNCY) | 2025-12-31 | $49.13M | +55.2% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $45.92M | -39.9% |
| Medicinova Inc (MNOV) | 2025-12-31 | $45.60M | -18.4% |
| Coya Therapeutics, Inc. (COYA) | 2025-12-31 | $49.95M | +12.6% |
| NextCure, Inc. (NXTC) | 2025-12-31 | $50.18M | -37.9% |
Compare ATOS, AKTX, VRCA, VTGN side by side · Screen every company in Pharmaceutical Preparations ↗